Dr Paolo Tolomeo
- Honorary Research Fellow (School of Cardiovascular & Metabolic Health)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Solano, S. et al. (2025) Clinical characteristics and outcomes of patients with heart failure with preserved ejection fraction and with reduced ejection fraction according to the prognostic nutritional index: findings from PARADIGM‐HF and PARAGON‐HF. Journal of the American Heart Association, 14(1), e037782. (doi: 10.1161/JAHA.124.037782) (PMID:39719408)
Kondo, T. et al. (2024) A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials. Nature Medicine, 30(5), pp. 1432-1439. (doi: 10.1038/s41591-024-02941-8) (PMID:38710952) (PMCID:PMC11108780)
Tolomeo, P. et al. (2023) Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. European Heart Journal, 44(24), pp. 2202-2212. (doi: 10.1093/eurheartj/ehad210) (PMID:37051752)
Solano, S. et al. (2025) Clinical characteristics and outcomes of patients with heart failure with preserved ejection fraction and with reduced ejection fraction according to the prognostic nutritional index: findings from PARADIGM‐HF and PARAGON‐HF. Journal of the American Heart Association, 14(1), e037782. (doi: 10.1161/JAHA.124.037782) (PMID:39719408)
Kondo, T. et al. (2024) A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials. Nature Medicine, 30(5), pp. 1432-1439. (doi: 10.1038/s41591-024-02941-8) (PMID:38710952) (PMCID:PMC11108780)
Tolomeo, P. et al. (2023) Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. European Heart Journal, 44(24), pp. 2202-2212. (doi: 10.1093/eurheartj/ehad210) (PMID:37051752)